首頁 > 市場調查報告書 > 製藥

生物製劑

全球重組蛋白製造服務市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

市場調查報告書

商品編碼

1377879

全球重組蛋白製造服務市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global Recombinant Proteins Manufacturing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年09月01日 | 出版商:

Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球重組蛋白製造服務市場的市場規模將從 2022 年的 42.9 億美元達到近 164.5 億美元，2023-2030 年研究期間的CAGR為 18.29%。

重組蛋白製造服務是指生物技術和合約製造組織 (CMO) 提供的用於生產各種用途的重組蛋白的流程和設施。重組蛋白是由基因工程生物體（通常是細菌、酵母、哺乳動物細胞，甚至植物）產生的，以表達特定的目的蛋白。這些蛋白質用於各個領域，包括製藥、生物技術、研究、診斷和工業應用。

市場動態：

由於幾個關鍵因素，重組蛋白製造服務市場正在經歷成長。對單株抗體和疫苗等生物藥物的需求推動了生物製藥產業的擴張，這是主要驅動力。生物藥物擴大用於治療各種疾病，因此需要生產這些服務所提供的重組蛋白。生命科學和生物技術的研發活動、基因工程的進步以及合約製造的外包趨勢進一步刺激了需求。慢性病盛行率的上升、COVID-19 強調的大流行防範的必要性以及蛋白質表現和純化技術的不斷進步都促進了市場的成長。法規核准，尤其是生物製藥領域的法規核准，確保了對可靠且合規的製造服務的需求。新興市場和服務提供者提供的客製化選項也發揮了作用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球重組蛋白製造服務市場的每個細分市場進行包容性評估。重組蛋白製造服務產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲重組蛋白製造服務市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。重組蛋白製造服務市場的主要參與者包括 Lonza、Boehringer Ingelheim International GmbH、FUJIFILM Diosynth Biotechnologies、Merck KGaA、Bruker (InVivo BioTech Services GmbH)、Sino Biological, Inc.、GenScript、Kaneka Corporation (Kaneka Eurogentec SA)、Polyplus轉染（Xpress Biologics），Boster Biological Technology，Trenzyme GmbH。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：重組蛋白製造服務公司的競爭格局

重組蛋白製造服務市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
Lonza

公司簡介
公司收入
產品
最近的發展

Boehringer Ingelheim International GmbH

公司簡介
公司收入
產品
最近的發展

FUJIFILM Diosynth Biotechnologies

公司簡介
公司收入
產品
最近的發展

Merck KGaA

公司簡介
公司收入
產品
最近的發展

Bruker (InVivo BioTech Services GmbH)

公司簡介
公司收入
產品
最近的發展

Sino Biological Inc.

公司簡介
公司收入
產品
最近的發展

GenScript

公司簡介
公司收入
產品
最近的發展

Kaneka Corporation (Kaneka Eurogentec SA)

公司簡介
公司收入
產品
最近的發展

Polyplus Transfection (Xpress Biologics)

公司簡介
公司收入
產品
最近的發展

Boster Biological Technology

公司簡介
公司收入
產品
最近的發展

Trenzyme GmbH

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112112237

The global demand for Recombinant Proteins Manufacturing Services Market is presumed to reach the market size of nearly USD 16.45 BN by 2030 from USD 4.29 BN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.

Recombinant protein manufacturing services refer to the processes and facilities offered by biotechnology and contract manufacturing organizations (CMOs) to produce recombinant proteins for various purposes. Recombinant proteins are produced by genetically engineering organisms, typically bacteria, yeast, mammalian cells, or even plants, to express specific proteins of interest. These proteins are used in various fields, including pharmaceuticals, biotechnology, research, diagnostics, and industrial applications.

MARKET DYNAMICS:

The recombinant proteins manufacturing services market is experiencing growth due to several key factors. The expansion of the biopharmaceutical industry, driven by the demand for biologic drugs like monoclonal antibodies and vaccines, is a primary driver. Biologic drugs are increasingly used in treating various diseases, necessitating the production of recombinant proteins, which these services provide. Research and development activities in life sciences and biotechnology, advancements in genetic engineering, and the outsourcing trend in contract manufacturing further boost demand. The rising prevalence of chronic diseases, the imperative for pandemic preparedness highlighted by COVID-19, and ongoing technological advancements in protein expression and purification techniques contribute to the market's growth. Regulatory approvals, especially in the biopharmaceutical sector, ensure the demand for reliable and compliant manufacturing services. Emerging markets and the customization options service providers offer also play a role.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of recombinant proteins manufacturing services. The growth and trends of recombinant proteins manufacturing services industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the recombinant proteins manufacturing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

Pre-Clinical & Clinical Services
Commercial Production Services

By Host Cell

Mammalian Cells
Bacterial Cells
Insect Cells
Yeast & Fungi
Others

By End-User

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Proteins Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Proteins Manufacturing Services market include Lonza, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Merck KGaA, Bruker (InVivo BioTech Services GmbH), Sino Biological, Inc., GenScript, Kaneka Corporation (Kaneka Eurogentec S.A), Polyplus Transfection (Xpress Biologics), Boster Biological Technology, Trenzyme GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . RECOMBINANT PROTEINS MANUFACTURING SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Service Type
- 3.7.2 Market Attractiveness Analysis By Host Cell
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY SERVICE TYPE

5.1 Overview by Service Type
5.2 Historical and Forecast Data
5.3 Analysis by Service Type
5.4 Pre-Clinical & Clinical Services Historic and Forecast Sales by Regions
5.5 Commercial Production Services Historic and Forecast Sales by Regions

6 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY HOST CELL

6.1 Overview by Host Cell
6.2 Historical and Forecast Data
6.3 Analysis by Host Cell
6.4 Mammalian Cells Historic and Forecast Sales by Regions
6.5 Bacterial Cells Historic and Forecast Sales by Regions
6.6 Insect Cells Historic and Forecast Sales by Regions
6.7 Yeast & Fungi Historic and Forecast Sales by Regions
6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY END-USER

7.1 Overview by End-User
7.2 Historical and Forecast Data
7.3 Analysis by End-User
7.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
7.5 Academic & Research Institutes Historic and Forecast Sales by Regions

8 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RECOMBINANT PROTEINS MANUFACTURING SERVICES COMPANIES

9.1. Recombinant Proteins Manufacturing Services Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF RECOMBINANT PROTEINS MANUFACTURING SERVICES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Lonza
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Boehringer Ingelheim International GmbH
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. FUJIFILM Diosynth Biotechnologies
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Merck KGaA
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Bruker (InVivo BioTech Services GmbH)
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Sino Biological Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. GenScript
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Kaneka Corporation (Kaneka Eurogentec S.A)
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Polyplus Transfection (Xpress Biologics)
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Boster Biological Technology
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
10.13. Trenzyme GmbH
- 10.13.1. Company Overview
- 10.13.2. Company Revenue
- 10.13.3. Products
- 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Service Type (USD MN)
Pre-Clinical & Clinical Services Market Sales by Geography (USD MN)
Commercial Production Services Market Sales by Geography (USD MN)
Analysis Market by Host Cell (USD MN)
Mammalian Cells Market Sales by Geography (USD MN)
Bacterial Cells Market Sales by Geography (USD MN)
Insect Cells Market Sales by Geography (USD MN)
Yeast & Fungi Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis by End-User (USD MN)
Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
Academic & Research Institutes Market Sales by Geography (USD MN)
Global Recombinant Proteins Manufacturing Services Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Recombinant Proteins Manufacturing Services Report
Market Research Process
Market Research Methodology
Global Recombinant Proteins Manufacturing Services Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Service Type
Market Attractiveness Analysis by Host Cell
Market Attractiveness Analysis by End-User
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Service Type (USD MN)
Pre-Clinical & Clinical Services Market Sales by Geography (USD MN)
Commercial Production Services Market Sales by Geography (USD MN)
Global Market Analysis by Host Cell (USD MN)
Mammalian Cells Market Sales by Geography (USD MN)
Bacterial Cells Market Sales by Geography (USD MN)
Insect Cells Market Sales by Geography (USD MN)
Yeast & Fungi Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-User (USD MN)
Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
Academic & Research Institutes Market Sales by Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis